Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort. Issue 6 (28th September 2014)

• Record Type: Journal Article
• Authors: Morimoto, Yukiko; Maskarinec, Gertraud; Park, Song-Yi; Ettienne, Reynolette; Matsuno, Rayna K.; Long, Camonia; Steffen, Alana D.; Henderson, Brian E.; Kolonel, Laurence N.; Le Marchand, Loïc; Wilkens, Lynne R.
• Is Part Of: British journal of nutrition. Volume 112:Issue 6(2014)
• Page Start: 976
• Page End: 983
• Publication Date: 2014-09-28
• Subjects: Nutrition -- Periodicals; 572.4
• DOI: 10.1017/S0007114514001780
• Languages: English
• ISSNs: 0007-1145

Abstract

<abstract abstract-type="normal"> <title> <x content-type="archive" xml:space="preserve">Abstract</x> </title> <p>Given the high intake levels of soya and low incidence rates of breast cancer in Asian countries, isoflavones, substances with an oestrogen-like structure occurring principally in soyabeans, are postulated to be cancer protective. In the present study, we examined the association of dietary isoflavone intake with breast cancer risk in 84 450 women (896 <italic>in situ</italic> and 3873 invasive cases) who were part of the Multiethnic Cohort (Japanese Americans, whites, Latinos, African Americans and Native Hawaiians) with a wide range of soya intake levels. The absolute levels of dietary isoflavone intake estimated from a baseline FFQ were categorised into quartiles, with the highest quartile being further subdivided to assess high dietary intake. The respective intake values for the quartiles (Q1, Q2, Q3, and lower and upper Q4) were 0– < 3·2, 3·2– < 6·7, 6·7– < 12·9, 12·9– < 20·3, and 20·3–178·7 mg/d. After a mean follow-up period of 13 years, hazard ratios (HR) and 95 % CI were calculated using Cox regression models stratified by age and adjusted for known confounders. Linear trends were tested by modelling continuous variables of interest assigned the median value within the corresponding quartile. No statistically significant association was observed between dietary isoflavone intake and overall breast cancer risk (HR for upper Q4 <italic>v.</italic> Q1: 0·96 (95 % CI 0·85, 1·08); <italic>P</italic> trend = 0·40). While the test for interaction was not significant (<italic>P</italic>= 0·14), stratified analyses suggested possible ethnic/racial differences in risk estimates, indicating that higher isoflavone intakes may be protective in Latina, African American and Japanese American women. These results are in agreement with those of previous meta-analyses showing no protection of isoflavones at low intake levels, but suggesting inverse associations in populations consuming high amounts of soya.</p> </abstract>